Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOVORAFENIB for Brain neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 37 adverse event reports in the FDA FAERS database where TOVORAFENIB was used for Brain neoplasm malignant.

Most Reported Side Effects for TOVORAFENIB

Side Effect Reports % Deaths Hosp.
Accidental underdose 19 9.5% 0 0
Disease progression 16 8.0% 2 2
Rash 16 8.0% 0 1
Fatigue 15 7.5% 0 0
Off label use 13 6.5% 2 3
Headache 12 6.0% 0 3
Hair colour changes 11 5.5% 0 1
Blood creatine phosphokinase increased 10 5.0% 0 0
Acne 8 4.0% 0 1
Intracranial tumour haemorrhage 8 4.0% 0 2
Dermatitis acneiform 7 3.5% 0 1
Nausea 7 3.5% 0 1
Blood phosphorus decreased 6 3.0% 0 1
Growth retardation 5 2.5% 0 1
Melanocytic naevus 5 2.5% 0 0

Other Indications for TOVORAFENIB

Product used for unknown indication (64) Glioma (62) Astrocytoma (9) Astrocytoma, low grade (7) Brain neoplasm (5)

Other Drugs Used for Brain neoplasm malignant

PROCARBAZINE (2,283) TEMOZOLOMIDE (2,202) BEVACIZUMAB (740) TRAMETINIB DIMETHYL SULFOXIDE (317) LOMUSTINE (291) THALIDOMIDE (195) DABRAFENIB (189) IVOSIDENIB (140) SELINEXOR (136) AVAPRITINIB (122)

Related Pages

TOVORAFENIB Full Profile All Brain neoplasm malignant Drugs TOVORAFENIB Demographics TOVORAFENIB Timeline